ID: ALA1159888

Max Phase: Preclinical

Molecular Formula: C13H18N2O2

Molecular Weight: 234.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)NCC(O)COc1ccccc1C#N

Standard InChI:  InChI=1S/C13H18N2O2/c1-10(2)15-8-12(16)9-17-13-6-4-3-5-11(13)7-14/h3-6,10,12,15-16H,8-9H2,1-2H3

Standard InChI Key:  YTTFGUYTPJYRBQ-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-2 adrenergic receptor 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 234.30Molecular Weight (Monoisotopic): 234.1368AlogP: 1.30#Rotatable Bonds: 6
Polar Surface Area: 65.28Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.67CX LogP: 1.45CX LogD: -0.77
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.78Np Likeness Score: -1.08

References

1. IJzerman AP, Aué GH, Bultsma T, Linschoten MR, Timmerman H..  (1985)  Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.,  28  (9): [PMID:2993621] [10.1021/jm00147a037]

Source